These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
257 related items for PubMed ID: 26526575
1. Effects of the GSK-3β inhibitor (2Z,3E)-6-bromoindirubin-3'-oxime upon ovarian cancer cells. Yu AS, Zhao L. Tumour Biol; 2016 Apr; 37(4):4857-64. PubMed ID: 26526575 [Abstract] [Full Text] [Related]
2. Role of glycogen synthase kinase-3β inhibitor AZD1080 in ovarian cancer. Chen S, Sun KX, Feng MX, Sang XB, Liu BL, Zhao Y. Drug Des Devel Ther; 2016 Apr; 10():1225-32. PubMed ID: 27051274 [Abstract] [Full Text] [Related]
3. GSK-3β inhibitor 6-bromo-indirubin-3'-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells. Liu K, Li J, Wu X, Chen M, Luo F, Li J. Int J Oncol; 2017 Dec; 51(6):1821-1830. PubMed ID: 29039496 [Abstract] [Full Text] [Related]
4. 2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulates proliferation of HAPI microglia by affecting the Akt/GSK-3β/cyclin D1 signaling pathway. Xu G, Li Y, Yoshimoto K, Wu Q, Chen G, Iwata T, Mizusawa N, Wan C, Nie X. Toxicol Lett; 2014 Jan 30; 224(3):362-70. PubMed ID: 24231000 [Abstract] [Full Text] [Related]
5. The role of glycogen synthase kinase-3β (GSK-3β) in endometrial carcinoma: A carcinogenesis, progression, prognosis, and target therapy marker. Chen S, Sun KX, Liu BL, Zong ZH, Zhao Y. Oncotarget; 2016 May 10; 7(19):27538-51. PubMed ID: 27050373 [Abstract] [Full Text] [Related]
6. Emodin Inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer Cells via ILK/GSK-3β/Slug Signaling Pathway. Lu J, Xu Y, Wei X, Zhao Z, Xue J, Liu P. Biomed Res Int; 2016 May 10; 2016():6253280. PubMed ID: 28097141 [Abstract] [Full Text] [Related]
7. MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM. Liu HY, Zhang YY, Zhu BL, Feng FZ, Zhang HT, Yan H, Zhou B. J Ovarian Res; 2019 Jul 05; 12(1):60. PubMed ID: 31277702 [Abstract] [Full Text] [Related]
8. Emodin inhibits epithelial to mesenchymal transition in epithelial ovarian cancer cells by regulation of GSK-3β/β-catenin/ZEB1 signaling pathway. Hu C, Dong T, Li R, Lu J, Wei X, Liu P. Oncol Rep; 2016 Apr 05; 35(4):2027-34. PubMed ID: 26820690 [Abstract] [Full Text] [Related]
9. GSK-3β inhibition promotes engraftment of ex vivo-expanded hematopoietic stem cells and modulates gene expression. Ko KH, Holmes T, Palladinetti P, Song E, Nordon R, O'Brien TA, Dolnikov A. Stem Cells; 2011 Jan 05; 29(1):108-18. PubMed ID: 20960517 [Abstract] [Full Text] [Related]
10. Fascaplysin inhibit ovarian cancer cell proliferation and metastasis through inhibiting CDK4. Chen S, Guan X, Wang LL, Li B, Sang XB, Liu Y, Zhao Y. Gene; 2017 Nov 30; 635():3-8. PubMed ID: 28888575 [Abstract] [Full Text] [Related]
11. Effect of siRNA-silencing of SALL2 gene on growth, migration and invasion of human ovarian carcinoma A2780 cells. Miao F, Zhang X, Cao Y, Wang Y, Zhang X. BMC Cancer; 2017 Dec 11; 17(1):838. PubMed ID: 29228922 [Abstract] [Full Text] [Related]
12. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway. Ong CS, Zhou J, Ong CN, Shen HM. Cancer Lett; 2010 Dec 08; 298(2):167-75. PubMed ID: 20655656 [Abstract] [Full Text] [Related]
13. Inhibition of p90 ribosomal S6 kinase attenuates cell migration and proliferation of the human lung adenocarcinoma through phospho-GSK-3β and osteopontin. Abdulrahman N, Jaballah M, Poomakkoth N, Riaz S, Abdelaziz S, Issa A, Mraiche F. Mol Cell Biochem; 2016 Jul 08; 418(1-2):21-9. PubMed ID: 27236820 [Abstract] [Full Text] [Related]
14. The discovery of novel benzothiazinones as highly selective non-ATP competitive glycogen synthase kinase 3β inhibitors for the treatment of ovarian cancer. Gao Y, Ye DY, Zhou WC, Chu Y. Eur J Med Chem; 2017 Jul 28; 135():370-381. PubMed ID: 28460311 [Abstract] [Full Text] [Related]
15. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells. Kunnimalaiyaan M, Vaccaro AM, Ndiaye MA, Chen H. Mol Cancer Ther; 2007 Mar 28; 6(3):1151-8. PubMed ID: 17363508 [Abstract] [Full Text] [Related]
16. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth. Song EY, Palladinetti P, Klamer G, Ko KH, Lindeman R, O'Brien TA, Dolnikov A. Exp Hematol; 2010 Oct 28; 38(10):908-921.e1. PubMed ID: 20540984 [Abstract] [Full Text] [Related]
17. Glycogen synthase kinase 3β as a potential therapeutic target in synovial sarcoma and fibrosarcoma. Abe K, Yamamoto N, Domoto T, Bolidong D, Hayashi K, Takeuchi A, Miwa S, Igarashi K, Inatani H, Aoki Y, Higuchi T, Taniguchi Y, Yonezawa H, Araki Y, Aiba H, Minamoto T, Tsuchiya H. Cancer Sci; 2020 Feb 28; 111(2):429-440. PubMed ID: 31808966 [Abstract] [Full Text] [Related]
18. [Glycogen synthase kinase-3beta (GSK-3beta) promotes proliferation of ovarian cancer cells in vitro]. Cao Q, Feng YJ. Zhonghua Zhong Liu Za Zhi; 2006 Nov 28; 28(11):804-9. PubMed ID: 17415999 [Abstract] [Full Text] [Related]
19. Fangchinoline inhibits cell proliferation via Akt/GSK-3beta/ cyclin D1 signaling and induces apoptosis in MDA-MB-231 breast cancer cells. Wang CD, Yuan CF, Bu YQ, Wu XM, Wan JY, Zhang L, Hu N, Liu XJ, Zu Y, Liu GL, Song FZ. Asian Pac J Cancer Prev; 2014 Nov 28; 15(2):769-73. PubMed ID: 24568493 [Abstract] [Full Text] [Related]
20. Phosphorylation of glycogen synthase kinase-3 beta at serine 9 confers cisplatin resistance in ovarian cancer cells. Cai G, Wang J, Xin X, Ke Z, Luo J. Int J Oncol; 2007 Sep 28; 31(3):657-62. PubMed ID: 17671694 [Abstract] [Full Text] [Related] Page: [Next] [New Search]